Interventional Psychiatry is a Groundbreaking Subspecialty to Transform Mental Health Care
Written by Joao L. de Quevedo, MD, PhD Within the field of Psychiatry, various subspecialties have emerged to address the diverse and complex needs of individuals experiencing mental health disorders. These subspecialties include Child and Adolescent Psychiatry, focusing on the diagnosis…
Improving patient care for autistic individuals through a neurodiversity lens
By: Amy K. Izuno-Garcia, PhD & Jeremy Jabbour, MS The prevalence of autism spectrum disorder (ASD) is increasing, with childhood diagnoses having increased by over 400% since the beginning of the century: 1 in 36 children in the United States…
Neuroimmunology of Down Syndrome Regression Disorder
Written by Joao L. de Quevedo, MD, PhD Down Syndrome Regression Disorder (DSRD) is a perplexing condition that manifests as a significant loss of skills and abilities in individuals with Down syndrome (DS). While the exact mechanisms underlying DSRD remain elusive,…
Unlocking Hope through Deep Brain Stimulation for Treatment-Resistant Depression
Written by Joao L. de Quevedo, MD, PhD Depression, with its suffocating grip on the mind, is a relentless adversary for millions worldwide. Despite advances in therapy and medication, some individuals find themselves locked in a grim battle against treatment-resistant depression…
Here’s what happens to your body when you quit smoking- National Geographic
This is an excerpt from National Geographic. The risks of smoking are well-known. Here are the immediate and long-term health benefits of quitting. Every year, half a million Americans die from smoking – related causes, while an estimated 16 million…
The Transition to Adulthood and Autism Spectrum Disorder
By Antonio F. Pagán, PhD, Katherine A. Loveland, PhD, and Killian Rainey Hughes, PhD Transition to Adulthood for Autism While various causes have been proposed, for young adults with autism spectrum disorder (ASD), a lack of tailored services, social…
FDA Grants Breakthrough Status to LSD Formula and Opens a New Frontier in the Generalized Anxiety Disorder (GAD) Treatment
Written by Joao L. de Quevedo, MD, PhD In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has bestowed breakthrough therapy status upon an LSD formula for the treatment of generalized anxiety disorder (GAD). This decision follows a…
Exploring Diverse TMS Protocols for Depression Treatment
Written by Joao L. de Quevedo, MD, PhD In the ever-evolving landscape of mental health care, Transcranial Magnetic Stimulation (TMS) has emerged as a versatile and effective intervention for depression. With a range of protocols available, each tailored to specific needs…
Brain Injury Awareness Day March 21
Written By: Dr. Deborah Little One major question I am asked frequently relates to patients with brain injury wanting to predict when they may return to work following their brain injury. The answer to this question is quite complex. Part…
Almost 20 years since FDA approval of vagus nerve stimulation (VNS) for treatment-resistant depression (TRD)
Written by Joao L. de Quevedo, MD, PhD In the realm of mental health, depression often presents itself as a formidable adversary, capable of ensnaring individuals in its relentless grip. Despite the advancements in pharmacological and psychotherapeutic interventions, a subset of…